LexisNexis recently announced the winners of 40 under 40. Our Partner Gordon Tsang was recognised as one of the winners of LexisNexis 40 UNDER 40 and invited to attend the award ceremony luncheon held at The China Club on 14 October 2022.
The inaugural award aims to recognize 40 young talent aged 40 years old or under across various legal fields in mainland China, Hong Kong, Macau and Taiwan. Winners are selected for delivering the best and best-in-class work ethics to their clients, partners, and colleagues together with showing exceptional passion to grow and lead the development of the legal sector in Greater China.
Gordon Tsang | Partner
Practice Areas: China Practice, Corporate Commercial Law, Corporate Services, Corporate Finance
Gordon has experience handling a wide range of corporate and commercial matters, including pre-IPO restructuring and financing, Hong Kong and U.S. IPOs, mergers and acquisitions, loan and financing transactions, corporate governance and general compliance for listed companies as well as private enterprises.
Gordon is a Non-Executive Director of China Regenerative Medicine International Ltd (Stock Code: 8158), the Independent Non-Executive Director of Sterling Group Holdings Limited (Stock Code: 1825) and CROSSTEC Group Holdings Limited (Stock Code: 3893). He is also the Company Secretary of 1957 & Co. (Hospitality) Limited (Stock Code: 8495), Sunshine 100 China Holdings Ltd (Stock Code: 2608), Mabpharm Limited-B (Stock Code: 2181) and Sundy Service Group Co. Ltd (Stock Code: 9608).
Gordon has successfully assisted Magic Empire Global Limited (NASDAQ: MEGL), Intelligent Living Application Group Inc. (NASDAQ: ILAG), Zhong Yang Financial Group Limited (NASDAQ: TOP), Hywin Holdings Ltd. (NASDAQ: HYW) and Oriental Culture Holding Ltd (NASDAQ: OCG) on their NASDAQ listing.
For more information, please contact our Partner Gordon Tsang or visit Gordon’s profile on LexisNexis 40 UNDER 40 here.
